António Araújo
António Araújo is Head of the Department of Medical Oncology at Centro Hospitalar Universitário do Porto, and Full Professor at School of Medicine and Biomedical Sciences - ICBAS and at Dental Medical Faculty, University of Porto. Since January 2023, he is Head of the Integrated Master Degree in Medicine at School of Medicine and Biomedical Sciences – ICBAS, University of Porto. He is a member of the Portuguese National Council for Oncology since 2013 and a member of the Scientific Committee of the Portuguese National Cancer Registry since 2019. He was a member of the International Association for Study of Lung Cancer Ethics Committee for the term 2015-2019 and is a member of its Educational Committee since 2019. He was a member of the Executive Board of the Portuguese Lung Cancer Study Group, from 2006-2012. He is a founding member of REDICAP - Red IberoAmericana de Cancer de Pulmón, founded in February 2021, and which includes oncologic researchers from Spain, Colombia, Argentina, Peru and Portugal. He was President of the Executive Board of the Northern Regional Council of the Portuguese Medical Association from 2017-2022. Professor Araújo has authored or contributed to more than 110 scientific papers and book chapters. He is a full member of ESMO, ASCO, IASLC, Portuguese Society of Oncology, and the Portuguese Society of Pulmonology. In 2022, he was distinguished with the Municipal Medal of Merit – Gold Grade, by the city of Porto.
Matthijs Oudkerk
Professor Matthijs Oudkerk is professor emeritus of Radiology at the University of Groningen, Chief Scientific Officer of the Institute for Diagnostic Accuracy (formerly the Center of Medical Imaging Research Center of Excellence awarded by the Dutch Research Council) and the principal investigator for Radiology of the NELSON lung cancer detection study (published in the New England Journal of Medicine 2020) the ROBINSCA study on early detection of cardiovascular disease and the 4-In-the-Lung-Run-Study (4ITLR) on implementation of screening and early detection of lung cancer, cardiovascular disease and emphysema in Europe (inclusion started in 2022). In 2020 he chaired the Expertgroup of the National Institute of Public Health of the Netherlands and published the Report: Diagnosis, Prevention, and Treatment of Thromboembolic Complications in COVID-19 published in Radiology(2020). Oudkerk was Founder and President of the European Society of Cardiac Radiology and presented the first study on non-invasive imaging of the coronaries with CT published in the Lancet 2001: He was Chairman of Radiology departments of DDHK Erasmus MC Rotterdam and University Medical Center Groningen. Oudkerk received a prestigious grant of Royal Academy of Sciences of the Netherlands (KNAW) for the early detection of lung cancer. Furthermore grants such as Horizon2020 grant, ERC advanced grant, Dutch Research Council, etc. Today Oudkerk focuses as chief scientific officer of the Institute of Diagnostic Accuracy (i-dna.org) on implementation of the B3 diseases together with research and validation of AI in large datasets operating in the advanced High Performance Computer Center Bytesnet in cooperation with EU and worldwide international partners in multidisciplinary multi-center studies, spin-off scientific start-ups and through PhD exchange programs. He published more than 622 peer reviewed articles, is cited over 27,549 times with an H-index >80 (Scopus Oct 2022).Key publications in Nature, NEJM, Lancet, Thorax, Circulation, JACC, Eur Heart, Radiology, Lancet Oncology, etc. H-index Google Scholar 98, citations Google Scholar 118051.
Antoni Rosell
Dr. Antoni Rosell (Barcelona, 1963) Pulmonologist (1992), Ph.D. in Medicine (2000), Diploma in Biostatistics (2004), Euro-pean Certification in Respiratory Medicine (HERMES) (2009), and Professor of Medicine at the Universitat Autònoma de Barcelona (2021), he has held the position of Chief of Respiratory Endoscopy Unit of the Hospital Universitari de Bellvitge (Barcelona) between 2005 and 2018. Since then, he is the Clinical Director of the Thoracic Institute of the Hospital Universitari of the Germans Trias i Pujol Hospital (Barcelona), managing the Pulmonology Service and the Thoracic Surgery Service. He has made short stages in international hospitals and research centers between 1998 and 2013, learning autofluorescence, endobronchial ultrasound (EBUS), rigid bronchoscopy, and lung cancer screening programs. He has been the introducer in Spain of the EBUS, the autofluorescence bronchoscopy, and the non-electromagnetic navigation system (Archimedes©). During 2012-2018 he developed an international fellowship on interventional bronchoscopy. He is a referral in this field, specifically rigid bronchoscopy, and stenting. He leads the Translational Pulmonology Research Group of the Germans Trias Research Institute (IGTP). Dr. Rosell s a reviewer of research projects of various public health agencies and international journals. He published 22 articles in Q1, h-Index of 16, and is the co-author of 3 patents. Together with the group of chemists, an antibiofilm silver-eluting stent was developed and tested in an animal model. His research is focused on radiomics and radiogenomics applied in lung cancer screening, and he is participating in the International Lung Screen Trial (ISLT). He chaired the 3rd European congress of the EABIP (European Association for Bronchology and Interventional Pulmonology) in 2015 and has been the vice president of the World Conference of Lung Cancer (WCLC) in Barcelona (2019).
Witold Rzyman
After graduating from medical studies in 1986 at the Silesian Medical University in Katowice in Poland, he began surgical education in the Department of Vascular and General Surgery. Since 1993 he has been employed in Thoracic Surgery Department of Medical University of Gdansk (MUG) being assistant professor and from 2008 university professor. Appointed in 2006 to the position of Chief Surgeon of Thoracic Surgery Department of MUG. Since 2008, apart from the duties related to the MUG, he has been the Chief Surgeon of Thoracic Surgery Department of the Provincial Hospital of Lung Diseases in Prabuty. In the years 1995-2010 he worked periodically (40 months) at the Department of Cardiac Surgery at Ullevål University Hospital in Oslo. He is the author of over 108 publications and has been awarded numerous academic prizes and honors such as Board member of Polish Society of Cardiothoracic Surgery and Polish Thoracic Surgeons Club; Former Member of ESTS Ad Hoc Screening Committee; and IASLC Screening Committee Member. He is Associate Editor of the International Lung Cancer News. His scientific interests are thoracic malignancies with a special emphasis on multimodality treatment and minimally invasive surgical procedures. In addition to strictly surgical interests, he is involved in biomolecular projects as a co-leader of Gdansk Lung Cancer Study Group, responsible for biobanking. However, the core of his non-surgical activity is the implementation of LDCT lung cancer screening in Poland and globally being initiator and the Steering Committee Member of the Polish Pilot LCS program 2020-2023. He is involved in several lung cancer screening initiatives in Europe, including the Lung Cancer Policy Network. PI of three grants: “Pilot Pomeranian Lung Cancer Screening Program” (2009-2011), “MOLTEST 2013” and “MOLTEST-BIS” the studies that evaluate molecular tests supporting LDCT lung cancer screening in screening program participants. Co-investigator in “CLEARLY”, a study within Horizon 2020 program.